Partner with SkinVision to shift melanoma detection from late-stage crisis to early-stage prevention — reducing claim severity by up to 96% while championing member wellbeing.
Skin analysis complete.
No immediate concerns detected.
Keep monitoring.
Skin cancer is the most common cancer globally, yet the majority of melanomas are still caught too late — driving devastating outcomes and enormous claim costs.
People globally will face skin cancer. 90% of cases are directly tied to UV radiation exposure.
Over half of melanomas caught at Stage III/IV, when treatment becomes complex and costly.
Peak diagnosis falls within the insured workforce demographic.
Western Europe achieves >90% survival; regional rates drop below 60%.
Shifting diagnosis from late to early stage reduces claim severity — from complex oncology to routine dermatology.
A CE-certified, AI-powered mobile medical device delivering clinical-grade skin risk assessment in seconds.
Scientifically proven algorithm with >90% sensitivity across the three most common skin cancers.
CE-certified, BSI-audited, GDPR compliant mobile medical app available on iOS and Android.
Low, Low-Symptoms, or High risk assessment in seconds with recommended next steps.
Four steps from awareness to actionable health insight — no IT integration required.
Member clicks a deep-link or QR code inside your Insurer Member Portal.
Seamless routing to App Store or Google Play, bypassing consumer paywalls.
Guided in-app camera captures a photo of any concerning skin lesion.
Immediate AI assessment and actionable next steps within seconds.
Radically reduce oncology claim payouts through systematic early detection.
Position your organization as a proactive health champion.
Monthly aggregated population health data and engagement reports.
Annual plan with unlimited smart checks and dermatology panel reviews.
24/7 access to clinical-grade skin health insights from anywhere.
In-app and email support with responses under 24 hours.
100,000 member population · melanoma incidence 10 cases / 100k.
4.5 early-stage, 5.5 late-stage cases
Total annual oncology claim cost
9 early-stage, 1 late-stage case
Total annual oncology claim cost
Model based on melanoma incidence only. Early detection of BCC and SCC prevents costly reconstructive surgeries, pushing actual ROI substantially higher.
Fully GDPR & UK GDPR compliant.
Independent Data Controller with strict data minimization.
Platform available 24/7, 365 days.
>99% guaranteed uptimeFirst reply <24h. CSAT target >90%.
Indemnity insurance up to €1,000,000.
per eligible member / year
12-month standard term, 6-month notice period. Automated monthly invoicing on active eligible members.
Structured Run-Off periods ensure continuous protection during transitions.
Monthly eligibility exchange; engagement reports delivered within 5 days of month-end.
Fixed pricing for 100k+ populations. Volume tiers for larger portfolios.
Three steps to launch a best-in-class digital skin health program for your members.
Interested in exploring a strategic partnership? I'd be happy to walk you through our platform, discuss tailored deployment for your member population, and share outcomes from our existing insurer partnerships across Europe and beyond.